Lan Nick S R, Chen Ruofei Trophy, Dwivedi Girish, Watts Gerald F, Nicholls Stephen J, Nelson Adam J
Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia.
Medical School, The University of Western Australia, 35 Stirling Highway, Crawley, Perth, WA, 6009, Australia.
Curr Cardiol Rep. 2025 Jan 8;27(1):9. doi: 10.1007/s11886-024-02174-8.
Lowering low-density lipoprotein (LDL)-cholesterol reduces cardiovascular risk. International lipid management guidelines recommend LDL-cholesterol goals or thresholds for initiating lipid-lowering therapy. However, contemporary real-world studies have shown that many high- and very high-risk patients are not attaining LDL-cholesterol goals and are not receiving intensive lipid-lowering therapies. In this review, recent examples of implementation strategies for optimising lipid management are discussed.
Implementation studies are heterogenous in their strategies and design. At the clinician level, multidisciplinary team-based care (including multidisciplinary lipid clinics), pharmacist- or nurse-led interventions, decision-support algorithms or protocols, and educational initiatives have shown potential to improve lipid management. Various strategies to improve patient adherence to lipid-lowering therapies have demonstrated at least short-term efficacy, including education, shared decision-making, behavioural support and nudges. Electronic health records can be leveraged at low cost to identify patients requiring initiation or intensification of lipid-lowering therapies, but the optimal method of integrating automated alerts or nudges to influence decision-making requires further research. Moreover, telehealth and remote care delivery models can improve access to healthcare and facilitate lipid-lowering. Multifaceted strategies with a systematic approach to targeting clinician, patient and system related factors can be successful in improving lipid management. Future implementation research should evaluate longer-term outcomes and follow implementation science theories, models and/or frameworks at all stages. By doing so, ongoing implementation studies will help researchers better understand the impact, sustainability and scalability of strategies, and where barriers and facilitators to lipid management may exist in other contexts.
降低低密度脂蛋白(LDL)胆固醇可降低心血管风险。国际血脂管理指南推荐了启动降脂治疗的LDL胆固醇目标或阈值。然而,当代的真实世界研究表明,许多高危和极高危患者未达到LDL胆固醇目标,也未接受强化降脂治疗。在本综述中,将讨论近期优化血脂管理实施策略的实例。
实施研究在策略和设计上具有异质性。在临床医生层面,基于多学科团队的照护(包括多学科血脂门诊)、药剂师或护士主导的干预措施、决策支持算法或方案以及教育举措已显示出改善血脂管理的潜力。多种提高患者对降脂治疗依从性的策略已证明至少具有短期疗效,包括教育、共同决策、行为支持和助推。可低成本利用电子健康记录来识别需要启动或强化降脂治疗的患者,但整合自动提醒或助推以影响决策的最佳方法仍需进一步研究。此外,远程医疗和远程照护交付模式可改善医疗服务可及性并促进降脂治疗。采用系统方法针对临床医生、患者和系统相关因素的多方面策略可成功改善血脂管理。未来的实施研究应评估长期结果,并在各个阶段遵循实施科学理论、模型和/或框架。这样做,正在进行的实施研究将帮助研究人员更好地理解策略的影响、可持续性和可扩展性,以及在其他环境中可能存在的血脂管理障碍和促进因素。